Are Medical Stocks Lagging Agenus (AGEN) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Agenus (AGEN) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Agenus is one of 1013 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Agenus is currently sporting a Zacks Rank of #2 (Buy).Over the past three months, the Zacks Consensus Estimate for AGEN's full-year earnings has moved 33.3% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.Our latest available data shows that AGEN has returned about 27.7% since the start of the calendar year. In comparison, Medical companies have returned an average of 5.6%. This means that Agenus is outperforming the sector as a whole this year.Another Medical stock, which has outperformed the sector so far this year, is Concentra Group (CON). The stock has returned 18.8% year-to-date.The consensus estimate for Concentra Group's current year EPS has increased 4.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, Agenus belongs to the Medical - Biomedical and Genetics industry, a group that includes 512 individual stocks and currently sits at #73 in the Zacks Industry Rank. Stocks in this group have gained about 5% so far this year, so AGEN is performing better this group in terms of year-to-date returns.Concentra Group, however, belongs to the Medical Services industry. Currently, this 59-stock industry is ranked #178. The industry has moved +2% so far this year.Agenus and Concentra Group could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agenus Inc. (AGEN): Free Stock Analysis Report Concentra Group Holdings Parent, Inc. (CON): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks